Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months.

J Diabetes Complications

Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, USA.

Published: December 2020

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jdiacomp.2020.107757	DOI Listing

Publication Analysis

treatment benfotiamine

benfotiamine patients

patients diabetic

diabetic sensorimotor

sensorimotor polyneuropathy

polyneuropathy double-blind

double-blind randomized

randomized placebo-controlled

placebo-controlled parallel

parallel group

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!